“11 times more effective against omicron” – researchers see “breakthrough potential”

Research outdoes itself in new findings about the corona virus. Australian researchers now want to have developed a “vaccination patch”.

Brisbane – A cast against Corona? The corona pandemic is accompanied by almost daily reports on the progress of research on the pandemic. The Bitter Realization: Many of them turn out to be only supposed breakthroughs. Researchers from the University of Brisbane have just published a new study which they consider to have “revolutionary” potential in the field of vaccination against the coronavirus.

The approaches are always interesting: It is about vaccination by a patch. It’s still too early to tell how promising the results of the “vaccination patch” really are. A special antibody had only recently been found. The momentum of the search gives hope for a cure.

Plasters against Corona: Australian researchers believe in corona vaccination with vaccination plasters

While German politicians are discussing new corona rules, there are already new research reports. This time they come from researchers at the University of Queensland: they believe they have developed a corona patch that works like a vaccine. But that’s not all: according to the researchers, the patch should be more effective than previous injection vaccinations. The Australian university scientists hope to be able to use the vaccine patch as a corona vaccine against various subtypes in the future, such as against Omikron, its subline Omikron BA.5 and others.

Patch against Corona: “11 times more effective against the omicron variant”

The team sees a “revolutionary potential” in it. In a statement from the university, study author Dr. Christopher McMillan: “We found that vaccination via a patch was approximately 11 times more effective in controlling the omicron variant than the same vaccine given via a patch. needle. A lot is happening in science: just recently a special antibody was discovered. The problem: there is a long way to go before the respective initial discoveries become definitive treatment or vaccination methods, sometimes promising hypotheses turn out to be a dead end – but not always.

Corona vaccine patch: University of Queensland study with biotech company Vaxxas – in mice

The vaccine patch study was conducted in mice by the University of Queensland in cooperation with Brisbane biotech company Vaxxas. Study author McMillan talks about a vaccine patch that delivers the vaccine specifically to layers of the skin that are particularly rich in immune cells. The scientist expects plaster to be another important tool at a time when corona variants such as Omicron are mutating particularly rapidly. McMillan spoke of the still great importance of previous vaccines with conventional vaccination methods. Meanwhile, Omikron BA.5 has new symptoms.

With our newsletter you will not miss anything from your surroundings, Germany and the world – register now for free!

The fact that the study was conducted on mice makes it clear that these are by no means “definitive” results – which, in the truest sense of the word, do not exist anyway. Mice are considered particularly important model organisms, but a definitive transferability of the study results to humans cannot be inferred. Yet it is another approach, albeit one of many, that may soon be forgotten. Only recently has there been new knowledge about a possible nasal spray vaccination. If the approaches actually prove to be compatible, that would be revolutionary: methods like these could make it easier to vaccinate children, whether it’s a nasal spray or a bandage.